Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of CVS Health Corp (NYSE: CVS) closed at $79.33 in the last session, down -1.67% from day before closing price of $80.68. In other words, the price has decreased by -$1.67 from its previous closing price. On the day, 4.49 million shares were traded. CVS stock price reached its highest trading level at $80.9643 during the session, while it also had its lowest trading level at $79.21.
Ratios:
We take a closer look at CVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.00. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.83. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $91.
On August 18, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $79.
Robert W. Baird Upgraded its Neutral to Outperform on August 14, 2025, while the target price for the stock was maintained at $82.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 20 ’25 when Finucane Anne A. sold 7,500 shares for $71.02 per share. The transaction valued at 532,650 led to the insider holds 22,156 shares of the business.
Finucane Anne A. bought 7,500 shares of CVS for $532,275 on Aug 20 ’25. On Jun 05 ’25, another insider, SANSONE GUY P, who serves as the Director of the company, bought 1,570 shares for $63.70 each. As a result, the insider paid 100,009 and bolstered with 12,007 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 100704075776 and an Enterprise Value of 171406082048. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 207.29, and their Forward P/E ratio for the next fiscal year is 11.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at 0.438 whereas that against EBITDA is 11.618.
Stock Price History:
The Beta on a monthly basis for CVS is 0.50, which has changed by 0.5527328 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $85.15, while it has fallen to a 52-week low of $50.14. The 50-Day Moving Average of the stock is 0.75%, while the 200-Day Moving Average is calculated to be 11.05%.
Shares Statistics:
According to the various share statistics, CVS traded on average about 7.35M shares per day over the past 3-months and 6726260 shares per day over the past 10 days. A total of 1.27B shares are outstanding, with a floating share count of 1.27B. Insiders hold about 0.14% of the company’s shares, while institutions hold 89.22% stake in the company. Shares short for CVS as of 1767139200 were 21665261 with a Short Ratio of 2.95, compared to 1764288000 on 19631638. Therefore, it implies a Short% of Shares Outstanding of 21665261 and a Short% of Float of 1.73.
Dividends & Splits
The forward annual dividend rate for CVS is 2.66, which was 2.66 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.032969758. The stock’s 5-year Average Dividend Yield is 3.17. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-10-23 with an ex-dividend date of 2026-01-22. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
. The current market rating for CVS Health Corp (CVS) reflects the collective analysis of 24.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $2.25, with high estimates of $2.47 and low estimates of $2.11.
Analysts are recommending an EPS of between $6.7 and $6.6 for the fiscal current year, implying an average EPS of $6.66. EPS for the following year is $7.17, with 29.0 analysts recommending between $7.5 and $6.91.
Revenue Estimates
According to 18 analysts,. The current quarter’s revenue is expected to be $103.67B. It ranges from a high estimate of $107.53B to a low estimate of $101.71B. As of. The current estimate, CVS Health Corp’s year-ago sales were $97.71BFor the next quarter, 18 analysts are estimating revenue of $96.65B. There is a high estimate of $100.83B for the next quarter, whereas the lowest estimate is $91.99B.
A total of 22 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $403.9B, while the lowest revenue estimate was $398.08B, resulting in an average revenue estimate of $400.12B. In the same quarter a year ago, actual revenue was $372.81BBased on 23 analysts’ estimates, the company’s revenue will be $409.91B in the next fiscal year. The high estimate is $425.63B and the low estimate is $400.17B.
